This Department of Defense (DoD) grant is for the Autism Research Program’s Clinical Trial Award, specifically supporting research with the potential to significantly impact the treatment or management of Autism Spectrum Disorder (ASD). This grant is exclusively for funding clinical trials, involving the prospective accrual of human subjects. The purpose is to test interventions, such as drugs, devices, behavioral interventions, or other modalities, for measurable outcomes regarding safety, effectiveness, or efficacy. This award does not support preclinical research studies or the initial development and proof-of-principle testing of interventions; these are addressed by other DoD grants.
Opportunity ID: 294474
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-ARP-CTA |
| Funding Opportunity Title: | DoD Autism Research Program, Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jun 07, 2017 |
| Last Updated Date: | Oct 06, 2017 |
| Original Closing Date for Applications: | Oct 19, 2017 |
| Current Closing Date for Applications: | Nov 14, 2017 |
| Archive Date: | Nov 18, 2017 |
| Estimated Total Program Funding: | $3,700,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider the FY17 ARP Idea Development Award (Funding Opportunity Number: W81XWH-17-ARP-IDA). Further, PIs seeking funding for the initial development and proof-of-principle testing of an intervention, and not a robust statistically powered clinical trial, should consider the FY17 ARP Clinical Translational Research Award (Funding Opportunity Number: W81XWH-17-ARP-CTRA). The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at https://ebrap.org/eBRAP/public/Program.htm. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The application submission deadline has been extended to 14 November 2017 and the end of the verification period has been extended to 17 November 2017. No other changes have been made. | Oct 06, 2017 | |
| Oct 06, 2017 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-ARP-CTA |
| Funding Opportunity Title: | DoD Autism Research Program, Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jun 07, 2017 |
| Last Updated Date: | Oct 06, 2017 |
| Original Closing Date for Applications: | Oct 19, 2017 |
| Current Closing Date for Applications: | Nov 14, 2017 |
| Archive Date: | Nov 18, 2017 |
| Estimated Total Program Funding: | $3,700,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider the FY17 ARP Idea Development Award (Funding Opportunity Number: W81XWH-17-ARP-IDA). Further, PIs seeking funding for the initial development and proof-of-principle testing of an intervention, and not a robust statistically powered clinical trial, should consider the FY17 ARP Clinical Translational Research Award (Funding Opportunity Number: W81XWH-17-ARP-CTRA). The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at https://ebrap.org/eBRAP/public/Program.htm. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-ARP-CTA |
| Funding Opportunity Title: | DoD Autism Research Program, Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 06, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Oct 19, 2017 |
| Archive Date: | Nov 18, 2017 |
| Estimated Total Program Funding: | $3,700,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider the FY17 ARP Idea Development Award (Funding Opportunity Number: W81XWH-17-ARP-IDA). Further, PIs seeking funding for the initial development and proof-of-principle testing of an intervention, and not a robust statistically powered clinical trial, should consider the FY17 ARP Clinical Translational Research Award (Funding Opportunity Number: W81XWH-17-ARP-CTRA). The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at https://ebrap.org/eBRAP/public/Program.htm. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Related Documents
Folder 294474 Full Announcement-FY17 ARP CTA -> ARP_FY17_CTA_PA_GG_updated dates.pdf
Folder 294474 Full Announcement-FY17 ARP CTA -> ARP_FY17_CTA_ECI Eligibility Statement_GG_updated dates.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00233048 | Jun 07, 2017 | Nov 14, 2017 | View |
Package 1
Mandatory forms
294474 RR_SF424_2_0-2.0.pdf
294474 RR_Budget_1_4-1.4.pdf
294474 PerformanceSite_2_0-2.0.pdf
294474 AttachmentForm_1_2-1.2.pdf
Optional forms
294474 RR_KeyPersonExpanded_2_0-2.0.pdf
294474 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
